Ruka hadi maudhui makuu

Condition · 1 treatment path

Small Cell Lung Cancer

Small cell lung cancer is an aggressive lung cancer closely linked to smoking. It grows and spreads quickly and is often found after it has already spread, though it is sensitive to treatment at first.

Severe

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Ilisasishwa mwisho: Jinsi tunavyokusanya na kukagua taarifa

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
1Treatment paths
Specialties
1Specialties
Typical severity
SevereTypical severity

About small cell lung cancer

What to know

Symptoms include persistent cough, breathlessness, coughing blood, chest pain, weight loss and tiredness, and sometimes hormone-related syndromes. Diagnosis uses CT and bronchoscopic or needle biopsy, with PET-CT and brain MRI to stage it as limited (confined to one side of the chest) or extensive stage.

Chemotherapy is the backbone of treatment. Limited-stage disease is treated with chemotherapy and chest radiotherapy given together, with prophylactic brain radiotherapy for responders. Extensive-stage disease is treated with chemotherapy plus immunotherapy, such as atezolizumab or durvalumab. Surgery is rare and only for very early tumours. Relapse is common, so support and palliative care are integral. Patients seek immunotherapy or trials abroad.

Pre-flight workup

Tests to have already done

  • Biopsy report confirming small cell carcinoma, from bronchoscopy, needle biopsy or a lymph node.
  • CT chest and abdomen, PET-CT, and MRI or CT of the brain to stage the disease as limited or extensive.
  • Blood tests: blood count, kidney and liver function, sodium and LDH.
  • Lung function tests and heart assessment, because fitness determines the treatment intensity.
  • Smoking history and performance status, plus treatment already given, with dates.

Second opinion

When to get a second look

  • Your disease has been called limited stage and you want to confirm whether chemoradiotherapy together is possible.
  • You have been told that no treatment is available, and your fitness has not been properly reviewed.
  • Your cancer has returned after treatment and options such as second-line drugs or trials are being considered.
  • Surgery is being considered for a very early tumour, which is only rarely suitable.

Talking to your doctor

Questions to ask

  1. Is my cancer limited stage or extensive stage, and what does the scan show?
  2. Which chemotherapy and immunotherapy combination do you recommend and for how many cycles?
  3. Can radiotherapy to the chest be given at the same time as chemotherapy?
  4. Should I have brain preventive radiotherapy or regular brain scans?
  5. What side effects should I expect and how will they be managed?
  6. What is the aim of treatment, and what follows if the cancer returns?

Outlook

Realistic prognosis

Small cell lung cancer responds well to initial treatment in many patients, but it commonly returns. Limited-stage disease treated with chemoradiotherapy has a meaningful chance of long-term survival, while extensive-stage disease is rarely curable, and treatment aims to control it and extend life. Stopping smoking and good fitness improve outcomes.

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For small cell lung cancer, plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.

  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.

  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.

  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

04 · FAQ

Common questions about small cell lung cancer

Can small cell lung cancer be cured?

A minority of patients with limited-stage disease are cured with chemoradiotherapy. Extensive disease is treated to control it, not cure it.

Why is treatment started quickly?

Because the cancer grows fast, delays can allow spread, though responses to chemotherapy are often rapid.

Does it spread to the brain?

It often does, which is why brain imaging is part of staging and preventive brain radiotherapy may be discussed.

Clinical context

Working up small cell lung cancer properly

A condition like small cell lung cancer is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Jinsi ukurasa huu ulivyoandaliwa

Mbinu na viwango vya uhariri

This small cell lung cancer overview is written by the editorial team from published Oncology sources and lists 1 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Taarifa za hospitali. Maelezo ya hospitali yanakusanywa kutoka vyanzo vya umma na tovuti za hospitali. Uidhinishaji (JCI, NABH na mengine) huonyeshwa pale tulipo na rekodi. Daima omba hospitali cheti chake cha sasa.
  2. Sifa za madaktari. Sifa, utaalamu na wasifu hutoka wasifu wa daktari hospitalini. Leseni hukaguliwa kwenye rejista ya baraza la kitaifa la madaktari tu pale wasifu unapoonyesha alama ya "Leseni imehakikiwa" yenye tarehe.
  3. Bei. Viwango vya bei ni vya kukadiria, vimekusanywa kutoka orodha za bei na vifurushi vya hospitali na huonyeshwa na tarehe ya mwisho ya kusasishwa. Unacholipa ni kile kilichoandikwa kwenye nukuu ya hospitali.
  4. Maandishi ya kitabibu. Imeandikwa na timu ya wahariri ya Medcasts kutoka vyanzo vya kliniki vilivyochapishwa. Isipokuwa ukurasa umetaja mhakiki kwa jina, haujakaguliwa na daktari.
  5. Uhuru. Hospitali haziwezi kulipa ili kubadilisha nafasi yao kwenye kurasa zetu.
Vyanzo vya taarifa za ukurasa huu
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Hatua inayofuata · Small Cell Lung Cancer

Free second opinion on your Small case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.